The pharmokinetic limitations of antioxidant treatment for COPD
Keywords: COPD; chronic obstructive pulmonary disease; FEV1; forced expiratory volume in 1 s; IL-1β; interleukin-1-beta; GM-CSF; granulocyte monocyte colony stimulating factor; NF-κB; nuclear factor kappa B; MAPK; mitogen activated protein kinase; EGCG; epigallo